LV232

DRUG2 trials

Sponsors

Vigonvita Life Sciences

Conditions

Healthy Subjects

Phase 1

Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers

CompletedNCT06070857

Vigonvita Life SciencesHealthy Subjects

Start: 2023-10-05End: 2025-11-17Updated: 2025-12-16

Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules

CompletedNCT06279533

Vigonvita Life SciencesHealthy Subjects

Start: 2024-02-27End: 2024-12-17Updated: 2025-11-24